Collegium shareholders elect all nine directors, approve say-on-pay, ratify auditor

COLLEGIUM PHARMACEUTICAL, INC

All nine director nominees re-elected; votes ranged from 25.9M to 28.3M for, with broker non-votes of ~2.46M.
Advisory say-on-pay approved with 27,953,926 for, 315,383 against, 90,502 abstentions.
Ratification of Deloitte & Touche as independent auditor for FY2023 passed with 30,742,534 for, 44,006 against, 29,155 abstentions.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of nine Directors to hold office until the 2024 Annual Meeting of Shareholders.

Proposal: director election
Outcome: passed

Exact text from the filing

Each of Rita Balice-Gordon, Garen Bohlin, Joseph Ciaffoni, John Fallon, John Freund, Michael Heffernan, Neil F. McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2024 Annual Meeting of Shareholders.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers.

Proposal: say on pay
Outcome: passed

Exact text from the filing

On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.

Proposal: auditor ratification
Outcome: passed

Exact text from the filing

Proposal 3 was approved by the Company's shareholders.

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

COLLEGIUM PHARMACEUTICAL, INC filing history →

Source: SEC EDGAR

accession 0001104659-23-062681

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.